Eurofins Reinforces Market Leadership in Environment Testing in Europe with the Acquisition of NUA & Water & Waste Laboratori...
21 December 2015 - 5:30PM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), the world leader in environment
testing services, announces the acquisition of NUA-Umweltanalytik
GmbH (“NUA”) and Water & Waste Gesellschaft für Umweltschutz
und chemische Laboratorien GmbH (“Water & Waste”), two of the
market leaders in environmental testing in Austria, and of
Radonlab, the premier radon testing laboratory in Norway.
NUA is one of the leading private laboratories for environmental
analyses in the Austrian market, and is renowned for water testing.
Founded in 1974, NUA’s 45 staff provides both chemistry and
microbiology analyses of water, soil and air to a large number of
both public and private clients, with a regional focus in Lower
Austria.
Waste & Water leads the market in soil and waste analysis,
and is a reference laboratory for water and site contamination
testing, as well as geotechnical analysis. The company employs 65
staff serving most of the local municipalities in Austria, as well
as the domestic building and construction industry. Waste &
Water is also the testing laboratory for 4 out of the 5 high
contamination waste sites in the country.
These 2 acquisitions secure the Group’s market leadership and
ensure that Eurofins has the most comprehensive service offering in
Austria. In addition, the complementarity of the services of the
two laboratories should result in significant cross-selling
opportunities, as well as a strong platform on which to expand the
Group’s footprint across the country.
In Norway, where Eurofins is already the market leader in
environment testing, the Group acquired the country’s premier
laboratory for radon testing. With radon exposure identified by the
World Health Organization as the second most important cause of
lung cancer1, and with Norway having the highest radon
concentrations in indoor air, the country has one of the most
stringent regulations on radon testing. Radonlab’s expertise in
this field is reflected in its strong relationships with local
municipalities as the reference laboratory for radon testing. This
acquisition provides Eurofins the competence in this increasingly
important niche market, which could be rolled-out more widely to
complement the Group’s existing portfolio of environment testing
services.
Comment from Dr. Gilles Martin, Eurofins CEO: “The acquisition
of NUA and Water & Waste in Austria, and Radonlab in Norway
reflects our commitment to expand both our geographical and
operating footprint, as well as reinforce our market leadership in
environment testing. These acquisitions are a further demonstration
of Eurofins’ commitment to build the best and widest-reaching
analytical testing network in the market.”
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food, environment and
pharmaceutical products testing. It is also one of the global
market leaders in agroscience, genomics, discovery pharmacology and
central laboratory services. In addition, Eurofins is one of the
key emerging players in specialty clinical diagnostic testing in
Europe and the USA.
With 20,000 staff in around 200 laboratories across 39
countries, Eurofins offers a portfolio of over 130,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products, as well as for innovative clinical
diagnostic. The Group provides its customers with high-quality
services, accurate results on time and expert advice by its highly
qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
1 http://www.who.int/mediacentre/factsheets/fs291/en/
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151220005017/en/
For more information, please visit
www.eurofins.com or contact:Eurofins Investor
RelationsPhone: +32-2-766 1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024